Literature DB >> 17149563

Persistent primary thunderclap headache responsive to gabapentin.

Ivan Garza1, David F Black.   

Abstract

We report the case of a woman with an apparent primary thunderclap headache which occurred frequently until she achieved a therapeutic dosage of gabapentin. Primary thunderclap headache is a rare type of headache that warrants significant testing to rule out more ominous possibilities. Whether gabapentin may help other primary thunderclap headache sufferers or not remains unclear. Further research is needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149563      PMCID: PMC3452219          DOI: 10.1007/s10194-006-0346-7

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  6 in total

Review 1.  Abrupt-onset severe headaches.

Authors:  Yo-El S Ju; Todd J Schwedt
Journal:  Semin Neurol       Date:  2010-03-29       Impact factor: 3.420

Review 2.  Headache and Its Approach in Today's NeuroIntensive Care Unit.

Authors:  Laxmi P Dhakal; Andrea M Harriott; David J Capobianco; William D Freeman
Journal:  Neurocrit Care       Date:  2016-10       Impact factor: 3.210

3.  [Thunderclap headache caused by cerebellar infarction].

Authors:  G Gossrau; C Dannenberg; H Reichmann; R Sabatowski
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

Review 4.  Focus on the management of thunderclap headache: from nosography to treatment.

Authors:  E Ferrante; Cristina Tassorelli; P Rossi; C Lisotto; G Nappi
Journal:  J Headache Pain       Date:  2011-02-18       Impact factor: 7.277

Review 5.  A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based?

Authors:  Emma Devenney; Hazel Neale; Raeburn B Forbes
Journal:  J Headache Pain       Date:  2014-08-14       Impact factor: 7.277

6.  Is gabapentin an effective treatment choice for hemicrania continua?

Authors:  Roderick C Spears
Journal:  J Headache Pain       Date:  2009-05-13       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.